USE OF AN IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO THE ABO SYSTEM
- 专利权人:
- Mazen Elzaabi
- 发明人:
- Mazen Elzaabi
- 申请号：
- US13140541
- 公开号：
- US20120039886A1
- 申请日:
- 2009.12.16
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- An embodiment relates to the use of an immonuglobulin (IgG) concentrate depleted of anti-A (AcaA) and anti-B (AcaB) antibodies for producing a drug intended for treating neonatal jaundice caused by maternal-fetal incompatibility with respect to the ABO system.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF AN IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO THE ABO SYSTEM
- USE OF IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO ABO SYSTEM
- Use of immunoglobulin G (IgG) concentrates with reduced anti-A and anti-B antibodies to treat neonatal jaundice caused by maternal-fetal incompatibility with ABO blood group
- USE OF NANOPARTICLES COATED WITH RED BLOOD CELL MEMBRANES TO TREAT HEMOLYTIC DISEASES AND DISORDERS
- Food composition effective in preventing vascular disease
